glp 1 gip triple agonist GLP-1 / / Glucagon Receptor (CAS 2381089-83-2) Retatrutide: How Triple GLP-1/GIP/Glucagon Receptor
Description
Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used for the management of type 2 diabetes and obesity, yet their long-term cardiovascular effects in high-risk populations continue to be actively evaluated
doi:10.7326/annals-25-00860.
J.AraiY
J Burn Care Res
doi:10.1042/bsr20241510 Li Z, Wu J, Song J, Wen Y
Obesity management for the treatment of type 2 diabetes: emerging evidence and therapeutic approaches
